Add like
Add dislike
Add to saved papers

Admission-Based Prevalence of Schizophrenia, Schizoaffective Disorder and Bipolar I Disorder in a Catchment Area in Sinop, Turkey.

OBJECTIVE: To provide registry-based prevalence estimates of schizophrenia, schizoaffective, and bipolar I (BPI) disorders in a defined area of Sinop, Turkey.

MATERIAL AND METHODS: All patients that presented to primary and secondary health services over three year time (2009-2011) with diagnosis of psychotic disorder (F06.1, F06.2, F10.5, F12.5, F19.5, F20-29, F30-31, F32.3, F33.3, F39 in ICD-10) covering a population of 73,503 aged 15-64 were included via case registry systems. All accessed case records were pooled. Case ascertainment and diagnostic assessment were achieved through structured clinical interview for DSM-IV, phone interview, or farming a best-estimated diagnosis via records on registers.

RESULTS: Registries provided 1,410 probable cases. The successful clinical reappraisal rate was 66.8% (n: 955) while, the final diagnoses were determined via phone interview or best-estimate diagnosis in the rest of the cases. Seven hundred twenty seven individuals were diagnosed with DSM-IV yielding a prevalence of 9.8 per 1,000 (95% confidence interval [CI]: 8.2-11.5). Registry-based prevalence of schizophrenia, schizoaffective disorder, BPI disorder, and depression with psychotic features were 3.6 (95% CI: 3.0-4.2), 1.1 (95% CI: 0.8-1.4), 2.7 (95% CI: 2.0-3.3), and 1.0 (95% CI: 0.6-1.3) per 1,000, respectively.

CONCLUSION: Ten individuals per 1,000 adult persons admit for any disorder with psychotic symptoms. Registry-based prevalence estimates are lower than the lifetime prevalence estimates. However, analyses of administrative data appear to provide information needed for effectively plan and implement psychiatric services.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app